Suvretta Capital Management’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Suvretta Capital Management’s Portfolio PNT Stock Details PNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2,627,000	Closed	-$19.2M	–	115
2022 Q4	$19.2M	Buy	2,627,000 +296,098	+13%	+$2.2M	0.8%	43
2022 Q3	$18M	Sell	2,330,902 -683,506	-23%	-$5.8M	0.75%	45
2022 Q2	$20.5M	Hold	3,014,408	–	–	0.78%	44
2022 Q1	$24M	Buy	3,014,408 +341,545	+13%	+$2.17M	0.73%	42
2021 Q4	$15M	Buy	2,672,863 +447,863	+20%	+$3.36M	0.29%	55
2021 Q3	$17.1M	Buy	2,225,000 +179,400	+9%	+$1.64M	0.29%	52
2021 Q2	$21M	Buy	2,045,600 +969,600	+90%	+$9.86M	0.31%	61
2021 Q1	$11.3M	Buy	+1,076,000	New	+$14.6M	0.17%	70

Other funds holding PNT

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Suvretta Capital Management's PNT Position: Q1 2023 in Review

Suvretta Capital Management sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q1 2023, closing a stake of 2,627,000 shares — an estimated $19.2M sold.

Suvretta Capital Management first reported a position in PNT in Q1 2021 and held it in 8 quarters. The position peaked at $24M in Q1 2022. 115 funds tracked by Wall St. Rank hold PNT as of Q1 2023.

Suvretta Capital Management reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Suvretta Capital Management sold 2,627,000 POINT Biopharma Global Inc. Common Stock shares in Q1 2023, an estimated $19.2M.
Suvretta Capital Management first reported a position in POINT Biopharma Global Inc. Common Stock in Q1 2021 and held it in 8 quarters.
Suvretta Capital Management's POINT Biopharma Global Inc. Common Stock position peaked at $24M in Q1 2022.
115 funds tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q1 2023.

Based on Suvretta Capital Management's 13F filing for Q1 2023, filed 15 May 2023.